论文部分内容阅读
1821年Coindent首先描述一部分患甲状腺肿的病人,于应用含碘药物治疗后出现一些酷似以后称为弥漫性甲亢(Grave或Basedow病)的症状。1910年Kocher详细研究了这种现象,将它称为碘甲亢(Jod-Basedow病)。从此,碘甲亢便被后来有的作者视为一种独立的疾病。本世纪三十年代,一些国家开展用碘化物防治地方性甲状腺肿工作后,碘甲亢的病例报告曾一度增加,用碘防治的方法因此受到批评而渐被放弃。但随后由于新的资料积累,人们对碘甲亢这一疾病是否存在逐渐产生疑问。在一些作者的推荐下,用碘防治的工作又逐渐恢复。几十年来,由于对碘甲亢认识的反复和碘防治工作的起落,以及其他原因,有关本病
In 1821, Coindent first described a group of patients with goitre as having some symptoms resembling what was later referred to as Grave or Basedow disease after treatment with iodine-containing medications. Kocher studied this phenomenon in detail in 1910, calling it Jod-Basedow’s disease. Since then, iodine hyperthyroidism was later considered by some authors as an independent disease. In the thirties of this century, after iodine was used in some countries to prevent and treat endemic goiter, cases of iodine hyperthyroidism have been reported for some time. Therefore, the method of prevention and treatment with iodine has been criticized and gradually abandoned. However, due to the accumulation of new data, people are gradually questioning the existence of iodine hyperthyroidism. In the recommendation of some authors, the work of iodine prevention and control has gradually recovered. For decades, due to repeated knowledge of iodine hyperthyroidism and iodine control ups and downs, and other reasons, the disease